WAVE Life Sciences Ltd
NASDAQ:WVE
WAVE Life Sciences Ltd
Interest Income Expense
WAVE Life Sciences Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Interest Income Expense
$8.6m
|
CAGR 3-Years
245%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Haw Par Corporation Ltd
SGX:H02
|
Interest Income Expense
S$164.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Interest Income Expense
-S$805k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
I
|
IX Biopharma Ltd
SGX:42C
|
Interest Income Expense
-S$1.6m
|
CAGR 3-Years
-101%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is WAVE Life Sciences Ltd's Interest Income Expense?
Interest Income Expense
8.6m
USD
Based on the financial report for Mar 31, 2024, WAVE Life Sciences Ltd's Interest Income Expense amounts to 8.6m USD.
What is WAVE Life Sciences Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
14%
Over the last year, the Interest Income Expense growth was 151%. The average annual Interest Income Expense growth rates for WAVE Life Sciences Ltd have been 245% over the past three years , 14% over the past five years .